Rafferty Asset Management
TARS icon

Rafferty Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Rafferty Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+3,242
New +$207K ﹤0.01% 1101
2026
Q1 		– Sell
-2,875
Closed -$235K – 1141
2025
Q4 		$235K Sell
2,875
-1,105
-28% -$82.5K ﹤0.01% 1052
2025
Q3 		$237K Sell
3,980
-1,790
-31% -$88.1K ﹤0.01% 1043
2025
Q2 		$234K Sell
5,770
-810
-12% -$36.5K ﹤0.01% 1025
2025
Q1 		$338K Sell
6,580
-224
-3% -$11.1K ﹤0.01% 931
2024
Q4 		$377K Sell
6,804
-848
-11% -$38.5K ﹤0.01% 973
2024
Q3 		$252K Buy
7,652
+171
+2% +$4.81K ﹤0.01% 1061
2024
Q2 		$203K Buy
+7,481
New +$252K ﹤0.01% 1138

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rafferty Asset Management's TARS Position: Q2 2026 in Review

Rafferty Asset Management opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 3,242 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1101 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in TARS as recently as Q4 2025.

Rafferty Asset Management first reported a position in TARS in Q2 2024 and has held it in 8 quarters since. The position peaked at $377K in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Rafferty Asset Management held 3,242 shares of Tarsus Pharmaceuticals worth $204K as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Rafferty Asset Management position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1101 holding.
  • Rafferty Asset Management first reported a position in Tarsus Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Rafferty Asset Management's Tarsus Pharmaceuticals position peaked at $377K in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.